Produktsname: | L-Glutamine, L-a-glutamyl-L-alanyl-L-a-glutamyl-L-a-aspartyl-L-leucyl-L-glutaminyl-L-valylglycyl-L-glutaminyl-L-valyl-L-a-glutamyl-L-leucylglycylglycylglycyl-L-prolylglycyl-L-alanylglycyl-L-seryl-L-leucyl-L-glutaminyl-L-prolyl-L-leucyl-L-alanyl-L-leucyl-L-a-glutamylglycyl-L-seryl-L-leucyl- |
CAS Registry Number: | 33017-11-7 |
Synonyme: | 805: PN: WO03059934 SEQID: 690 unclaimed sequence; 1771: PN: WO03060071 SEQID: 1795unclaimed; 303: PN: US20090175821 SEQID: 377claimed protein; Proinsulin connecting peptide (human),1-de-L-arginine-2-de-L-arginine-34-de-L-lysine-35-de-L-arginine-; 21: PN:US20040005669 SEQID: 15 unclaimed sequence; 2: PN: WO2006129095 SEQID: 2 unclaimed sequence; 7: PN: WO2005039627 SEQID: 9 unclaimedsequence; Human proinsulin C-peptide; 5: PN:WO2006035702 SEQID: 5 unclaimed protein; Proinsulinconnecting peptide,1-de-L-arginine-2-de-L-arginine-34-de-L-lysine-35-de-L-arginine- (8CI); 10: PN:US20050026826 SEQID: 10 unclaimed sequence;L-Glutamine, L-a-glutamyl-L-alanyl-L-a-glutamyl-L-a-aspartyl-L-leucyl-L-glutaminyl-L-valylglycyl-L-glutaminyl-L-valyl-L-a-glutamyl-L-leucylglycylglycylglycyl-L-prolylglycyl-L-alanylglycyl-L-seryl-L-leucyl-L-glutaminyl-L-prolyl-L-leucyl-L-alanyl-L-leucyl-L-a-glutamylglycyl-L-seryl-L-leucyl-; 34: PN: WO2008118390 SEQID: 2 unclaimed protein; 2: PN: CN101381727 SEQID: 2unclaimed sequence; 2: PN:WO2008118387 SEQID: 2 unclaimed protein; 198: PN: WO0069900 SEQID: 377 unclaimed sequence; 9: PN:WO2007132291 SEQID: 9 claimed sequence;ProinsulinC-peptide (human) (9CI); |
Molecular Structure: | |
Molecular Formula: | C129H211 N35 O48 |
Molecular Weight: | 3020.26 |